Home > Research > Publications & Outputs > Modulation of dendritic cell alternative activa...

Links

Text available via DOI:

View graph of relations

Modulation of dendritic cell alternative activation and function by the vitamin A metabolite retinoic acid

Research output: Contribution to journalJournal article

Published
  • Lucy H Jones
  • Peter C Cook
  • Alasdair C Ivens
  • Graham D Thomas
  • Alexander T Phythian-Adams
  • Judith E Allen
  • Andrew S MacDonald
Close
<mark>Journal publication date</mark>1/11/2015
<mark>Journal</mark>International Immunology
Issue number11
Volume27
Number of pages8
Pages (from-to)589-596
Publication statusPublished
Early online date20/04/15
Original languageEnglish

Abstract

The archetypal Th2 cytokine IL-4 has previously been shown to alternatively activate murine macrophages and, more recently, dendritic cells (DCs) both in vitro and in vivo. IL-4 has also been shown to induce Aldh1a2 (aldehyde dehydrogenase 1a2) expression in murine macrophages recruited to the peritoneal cavity. However, the influence of IL-4 on DC Aldh1a2 induction in vivo has not yet been addressed. In this work, we found that DCs show enhanced aldehyde dehydrogenase enzyme activity in vivo, which led us to investigate the impact of the vitamin A metabolite all-trans retinoic acid (RA) on DC alternative activation and function. Antagonism of RA receptors reduced production of resistin-like molecule alpha by DCs responding to IL-4, while addition of exogenous RA enhanced production of this marker of alternative activation. Functionally, RA increased DC induction of CD4(+) T-cell IL-10, while reducing CD4(+) T-cell IL-4 and IL-13, revealing a previously unidentified role for RA in regulating the ability of alternatively activated DCs to influence Th2 polarization.